NASDAQ
DVAX

Dynavax Technologies Corporation

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Dynavax Technologies Corporation Stock Price

Vitals

Today's Low:
$11.2600
Today's High:
$11.8000
Open Price:
$11.5400
52W Low:
$7.26
52W High:
$18.63
Prev. Close:
$11.6200
Volume:
1815669

Company Statistics

Market Cap.:
$1.425 billion
Book Value:
3.344
Revenue TTM:
$0.673 billion
Operating Margin TTM:
39.1%
Gross Profit TTM:
$0.235 billion
Gross Profit TTM:
$0.235 billion
Profit Margin:
34.6%
Return on Assets TTM:
19.7%
Return on Equity TTM:
92%

Company Profile

Dynavax Technologies Corporation had its IPO on 2004-02-19 under the ticker symbol DVAX.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Dynavax Technologies Corporation has a staff strength of 0 employees.

Stock update

Shares of Dynavax Technologies Corporation opened at $11.54 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $11.26 - $11.8, and closed at $11.27.

This is a -3.01% slip from the previous day's closing price.

A total volume of 1,815,669 shares were traded at the close of the day’s session.

In the last one week, shares of Dynavax Technologies Corporation have increased by +2.45%.

Dynavax Technologies Corporation's Key Ratios

Dynavax Technologies Corporation has a market cap of $1.425 billion, indicating a price to book ratio of 3.509 and a price to sales ratio of 2.119.

In the last 12-months Dynavax Technologies Corporation’s revenue was $0.673 billion with a gross profit of $0.235 billion and an EBITDA of $0.267 billion. The EBITDA ratio measures Dynavax Technologies Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Dynavax Technologies Corporation’s operating margin was 39.1% while its return on assets stood at 19.7% with a return of equity of 92%.

In Q2, Dynavax Technologies Corporation’s quarterly earnings growth was a positive 4945% while revenue growth was a positive 386%.

Dynavax Technologies Corporation’s PE and PEG Ratio

Forward PE
6.36
Trailing PE
6.91
PEG
0

Its diluted EPS in the last 12-months stands at $1.63 per share while it has a forward price to earnings multiple of 6.36 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dynavax Technologies Corporation’s profitability.

Dynavax Technologies Corporation stock is trading at a EV to sales ratio of 1.815 and a EV to EBITDA ratio of 4.932. Its price to sales ratio in the trailing 12-months stood at 2.119.

Dynavax Technologies Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Dynavax Technologies Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Dynavax Technologies Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Dynavax Technologies Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Dynavax Technologies Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Dynavax Technologies Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$11.27
52-Week High
$18.63
52-Week Low
$7.26
Analyst Target Price
$24.8

Dynavax Technologies Corporation stock is currently trading at $11.27 per share. It touched a 52-week high of $18.63 and a 52-week low of $18.63. Analysts tracking the stock have a 12-month average target price of $24.8.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Dynavax Technologies Corporation

The stock symbol (also called stock or share ticker) of Dynavax Technologies Corporation is DVAX

The IPO of Dynavax Technologies Corporation took place on 2004-02-19

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
Imv Inc (IMV)
$0.34
0.01
+3.23%
$1.08
-0.03
-2.7%
$1.92
-0.05
-2.54%
$5.03
-0.02
-0.4%
$0.66
-0.05
-6.69%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
$0.02
0.01
+100%
Oi S.A (OIBR-C)
$0
0
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.

Address

2929 SEVENTH STREET, SUITE 100, BERKELEY, CA, US